Cargando…
Manipulation of PBF/PTTG1IP Phosphorylation Status; a Potential New Therapeutic Strategy for Improving Radioiodine Uptake in Thyroid and Other Tumors
CONTEXT: The clinical effectiveness of ablative radioiodine treatment of thyroid tumors is limited by the availability of the sodium iodide symporter (NIS) at the plasma membrane (PM) for uptake of (131)I. A significant proportion of well-differentiated thyroid tumors are unable to concentrate suffi...
Autores principales: | Smith, V. E., Sharma, N., Watkins, R. J., Read, M. L., Ryan, G. A., Kwan, P. P., Martin, A., Watkinson, J. C., Boelaert, K., Franklyn, J. A., McCabe, C. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207948/ https://www.ncbi.nlm.nih.gov/pubmed/23678037 http://dx.doi.org/10.1210/jc.2012-3640 |
Ejemplares similares
-
Functional consequences of the first reported mutations of the proto-oncogene PTTG1IP/PBF
por: Imruetaicharoenchoke, W, et al.
Publicado: (2017) -
PTTG1-interacting protein (PTTG1IP/PBF) predicts breast cancer survival
por: Repo, Heli, et al.
Publicado: (2017) -
Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancer
por: Read, Martin L., et al.
Publicado: (2017) -
Pro-invasive Effect of Proto-oncogene PBF Is Modulated by an Interaction with Cortactin
por: Watkins, Rachel J., et al.
Publicado: (2016) -
Is There a Role for Unstimulated Thyroglobulin Velocity in Predicting Recurrence in Papillary Thyroid Carcinoma Patients with Detectable Thyroglobulin after Radioiodine Ablation?
por: Wong, Hilda, et al.
Publicado: (2012)